Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 8: Quick Look at NMPA/CDE Regulatory Updates for Jan-Feb 2026
Release time：2026-07-08
share:
Previous article：Issue 9: NMPA/CDE Guidelines and Industry Trends
next article：Issue 7: Recent Key NMPA/CDE Policies Summary
Back to list
You may also want to read
Lead product R & D and manufacturing upgrading with technological innovation, and provide the market with more competitive high-quality products with advanced technology and stringent standards
2026.04.22
Nanjing Leecan Co., Ltd. signed a major investment promotion project in Nanjing!
2022.04.21
Good news! Hefei Leecan Pharmaceutical has been approved for the "Drug Production License" A certificate!
2025.05.16
